Evolving Management Strategies for Treatment-Resistant Depression - Episode 11

Incorporating Esketamine into Practice for Treatment-Resistant Depression

May 27, 2021
Steven P. Levine, MD

Angelos Halaris, MD, PhD, APA, ACNP, CINP

Lisa Harding, MD

Patricia Ares-Romero, MD, FASAM

Additional variables that require consideration if treating appropriate patients with treatment-resistant depression with intranasal esketamine within certified treatment facilities.